This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Sheila Nolan - Innovator in Recombinant Paramyxoviruses
Introduction
Sheila Nolan is a prominent inventor based in Pleasantville, NY (US). She has made significant contributions to the field of virology, particularly through her innovative work on recombinant paramyxoviruses. Her research focuses on developing self-replicating infectious recombinant viruses that have potential applications in medicine.
Latest Patents
Sheila Nolan holds 1 patent for her invention titled "Attenuated human parainfluenza virus, methods and uses thereof." This invention provides self-replicating infectious recombinant paramyxoviruses, which are designed to include one or more attenuating mutations. In some embodiments, the recombinant paramyxovirus features a separate variant polynucleotide encoding a P protein and a separate monocistronic polynucleotide encoding a V protein. Additionally, her work includes recombinant paramyxoviruses that possess at least one temperature-sensitive mutation and one non-temperature-sensitive mutation. The patent also outlines compositions and methods for utilizing these recombinant paramyxoviruses effectively.
Career Highlights
Sheila Nolan is affiliated with the United States of America, as represented by the Secretary, Department of Health and Human Services. Her role in this esteemed organization highlights her commitment to advancing public health through innovative research and development.
Collaborations
Throughout her career, Sheila has collaborated with notable colleagues, including Mario H Skiadopoulos and Brian R Murphy. These partnerships have contributed to the advancement of her research and the successful development of her patented technologies.
Conclusion
Sheila Nolan's work in the field of recombinant paramyxoviruses exemplifies her dedication to innovation and public health. Her contributions are paving the way for future advancements in virology and therapeutic applications.